Drawing for REVIVE

USPTO serial 87528642

REVIVE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SMITH, REBECCA A
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REVIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steve D Beyer

STEVE D BEYER BEYER LAW GROUP LLP2595 EAST BAYSHORE ROAD SUITE 100PALO ALTO, CA 94303UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Defibrillators, Automated External DefibrillatorsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 5, 2019MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jul 4, 2019ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 3, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 16, 2018EX2GSOU EXTENSION 2 GRANTED—
Aug 7, 2018EXT2SOU EXTENSION 2 FILED—
Aug 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 15, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 14, 2018EX1GSOU EXTENSION 1 GRANTED—
Feb 12, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 7, 2018EXT1SOU EXTENSION 1 FILED—
Feb 7, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 6, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 12, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 12, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 22, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 3, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2017ALIEASSIGNED TO LIE—
Oct 17, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 16, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Oct 16, 2017EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Oct 16, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Oct 11, 2017DOCKASSIGNED TO EXAMINER—
Jul 22, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 18, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance